about
Structural features of proinsulin C-peptide oligomeric and amyloid statesInsulin solubility transitions by pH-dependent interactions with proinsulin C-peptideOral Delivery of Protein Drugs Bioencapsulated in Plant CellsMass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic controlAssociation between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals.In vivo quantitative visualization analysis of the effect of C-peptide on glomerular hyperfiltration in diabetic rats by using multiphoton microscopy.The clinical potential of C-peptide replacement in type 1 diabetes.C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young arab females.Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptideC-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activationC-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetesC-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.History and diagnostic significance of C-peptide.C-peptide promotes lesion development in a mouse model of arteriosclerosisThe role of immunomodulation therapy in autoimmune diabetesMetal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.GAD-alum (Diamyd)--a new concept for preservation of residual insulin secretion.What's new in diabetes: incretins and C-peptide.The latest pharmacotherapy options for type 1 diabetes.The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis.Therapies to Preserve β-Cell Function in Type 1 Diabetes.RETRACTED: The Research on the Impact of Green Beans Sports Drinks on Relieving Fatigue in Sports TrainingThe clinical potential of low-level C-peptide secretion.C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device.Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.GAD65: a prospective vaccine for treating Type 1 diabetes?How the immunoassay transformed C-peptide from a duckling into a swan.Proinsulin C-peptide regulates ribosomal RNA expressionImmune intervention at diagnosis--should we treat children to preserve beta-cell function?Conditions of gestation, childbirth and childhood associated with C-peptide in young adults in the 1982 Birth Cohort in Pelotas-RS; Brazil.C-peptide evolution: generation from few structural restrictions of bioactivities not necessarily functional.Expression and Purification of C-Peptide Containing Insulin Using Pichia pastoris Expression System.pH-Dependent Interaction between C-Peptide and Phospholipid BicellesEtiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.C-peptide as a remedy for diabetic microangiopathy?
P2860
Q24297373-97F17497-2041-42FE-9B84-A49DBF3EC650Q24302077-AF1365E3-C1CB-4910-AF37-C711A9F1CA56Q28079063-809129B4-3323-4D03-9332-0C94A644B009Q33526376-38322790-606B-4791-A906-B195B859B4BCQ33583006-E2EFCC0B-1EE3-4551-B76A-A1BB19E02F5CQ33610661-8E828655-5EC9-44EA-8DCA-148A0F7D7909Q34822621-56C36E6C-78DA-4DE7-BA1B-5C5D1F2906B7Q34977954-45720C63-4ACF-407F-9015-049918BA33E0Q35857755-F422A32F-4F99-4E4B-B1D6-C62792173FB0Q36151881-A43AE281-4297-4040-982C-386C853CE638Q36344923-20EB81DB-44FA-4CEA-B11F-D4D19742BC4BQ36477346-D3CC2773-7093-4CBB-A9AF-51F2E50E6179Q36629649-CBF63D7F-C01C-4948-8463-9442DE2E7033Q36640081-5132A456-9275-4397-B7C9-ACBA4233042CQ37113466-9FC39DE7-FFFE-4C2F-B7F3-C6D2C6325217Q37134023-08D23218-6A16-4832-BC82-AF8291BD4623Q37147785-2873BEC1-1096-4435-9A43-D653EB6B8962Q37176063-DAD58A3E-1158-4740-A778-C902CF4404CCQ37294671-608D6DF4-5BC9-4FB6-8767-7FDBE3CA7B74Q37408019-D652BDD8-2683-4608-8CE3-92CFBD7E98EEQ37426635-0CF43959-5633-4E33-B1C1-CF04FA3D6B1FQ37709361-05EFC03D-97FC-48D6-B29B-FECB8E668566Q37831000-929044CB-A823-4FB4-8784-BE2FE4F037F1Q38167387-1D890914-D55B-4B6E-A681-57ABB7C2AF4AQ38216760-09DF29FB-8AF0-4E0B-AA04-79173A2F08AAQ38662048-A2E0F052-F62B-4178-A12F-805FB25E02C5Q38718949-3BC3D546-3DDC-4F5C-BE9C-0CE5B1005DDEQ38889362-2DD74604-96FD-4CB2-863A-722C33D9C841Q38892829-C0681B16-67FC-463F-B55E-BB9ED82D303CQ39007804-BDCC3E77-6C94-4D2E-8D60-50DE769F3D9DQ39290175-7C898861-6F48-44B0-8A37-D6387C4C3121Q39664344-B255D4BB-E019-40EF-95F5-2898289DE041Q39773904-1E117395-7814-43EF-8E4F-D72F7F7614F2Q40161327-68B7839C-D1A3-4032-B023-7B5BA25969CDQ40485115-31F8C7C3-385E-4259-98AF-2FBA461E3C58Q41572524-2D964411-AE64-4D47-B692-40697DC6A9FFQ41694997-1FB69726-1A2D-4810-87A8-AF5A510775ADQ41888120-979AEF21-78F7-4260-97FE-5AD280DBFF3DQ42041838-05CD5DDA-87A5-4C5C-9BB2-AB6A75030E54Q42418967-C1749A0E-3ACE-4A84-94B2-4171C9ABCEBB
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
C-peptide is a bioactive peptide.
@ast
C-peptide is a bioactive peptide.
@en
C-peptide is a bioactive peptide.
@nl
type
label
C-peptide is a bioactive peptide.
@ast
C-peptide is a bioactive peptide.
@en
C-peptide is a bioactive peptide.
@nl
prefLabel
C-peptide is a bioactive peptide.
@ast
C-peptide is a bioactive peptide.
@en
C-peptide is a bioactive peptide.
@nl
P1433
P1476
C-peptide is a bioactive peptide.
@en
P2093
P2888
P304
P356
10.1007/S00125-006-0559-Y
P50
P577
2007-01-18T00:00:00Z
P5875
P6179
1051626416